drugset / Trial / NCT00003485
Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Current therapies for metastatic or unresectable Colon Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of metastatic or unresectable Colon Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with metastatic or unresectable Colon Cancer
Timeline
- Start
- 1996-04-10
- Primary completion
- 2003-05-11
- Completion
- 2003-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | antineoplaston A10 | Small molecule | — | Intravenous |
| Subject | antineoplaston AS2-1 | Unknown | — | Intravenous |